Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Language menu
  5. Go to Help menu
  6. Go to modules
  7. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 
Empowering Life

Welcome to Sanofi
in Hong-Kong

 

Committed to discovering, developing and distributing therapeutic solutions to improve the lives of everyone, Sanofi is a leading global pharmaceutical company. Number 1 in Europe, the Group is present in more than 100 countries and is growing rapidly. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY) and has one of the largest market capitalizations in Paris.

     
     
     

    Content :

    Contact us

    Sanofi

    Units 706-710, Level 7,
    Core C, Cyberport 3,
    100 Cyberport Road,
    Hong Kong

    Tel.: (852) 2506 8333
    Fax: (852) 2506 2537

    Sanofi Pasteur
    Sanofi TV

    Welcome to Sanofi in Hong Kong

    Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

    With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. In Hong Kong & Macau, we have been serving the community for more than 30 years, equipped with a diverse talent of 130-strong team.

    Sanofi, Empowering Life

     
    Happy company
    Caring company - 5 consecutive years
    1st Manpower Developer Award
    Logo Corporate Award 2016
    HSBC Living Business

    News

    October 16, 2017

    Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

    October 12, 2017

    Sanofi invests €170 million in new vaccine production facility in France

    October 11, 2017

    Availability of the Pre-quarterly Results Communication

    October 02, 2017

    Sanofi Appoints Stefan Oelrich Executive Vice President Diabetes & Cardiovascular and Member of the Executive Committee